Inogen (INGN) Research & Development (2013 - 2026)
Inogen (INGN) reported Research & Development of $5.1 million for Q1 2026, up 26.35% year-over-year from $4.0 million in Q1 2025, and down 4.12% on a QoQ basis from $5.3 million in Q4 2025.
Inogen (INGN) has 14 years of Research & Development data on file, last reported at $5.1 million in Q1 2026.
- Quarterly Research & Development rose 26.35% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.5 million (up 7.32% YoY) and the FY2025 annual result came in at $19.4 million, down 10.23% from the prior year.
- Research & Development slipped to $5.1 million in Q1 2026 per INGN's latest filing, from $5.3 million in the prior quarter.
- Across five years, Research & Development topped out at $6.7 million in Q4 2023 and bottomed at $3.5 million in Q3 2024.
- The 5-year median for Research & Development is $5.3 million (2025), against an average of $5.2 million.
- The widest annual swing landed in 2022, when Research & Development surged 47.08%; it then plunged 38.67% in 2025.
- Tracing INGN's Research & Development over 5 years: stood at $5.9 million in 2022, then grew by 13.14% to $6.7 million in 2023, then retreated by 12.15% to $5.9 million in 2024, then declined by 9.87% to $5.3 million in 2025, then fell by 4.12% to $5.1 million in 2026.
- Per Business Quant, the three latest INGN Research & Development figures stand at $5.1 million (Q1 2026), $5.3 million (Q4 2025), and $4.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 5.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 5.32 Mn |
| Sep 30, 2025 | 4.84 Mn |
| Jun 30, 2025 | 5.21 Mn |
| Mar 31, 2025 | 4.03 Mn |
| Dec 31, 2024 | 5.90 Mn |
| Sep 30, 2024 | 3.52 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 6.58 Mn |
| Dec 31, 2023 | 6.71 Mn |
| Sep 30, 2023 | 4.49 Mn |
| Jun 30, 2023 | 4.29 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 6.06 Mn |
| Mar 31, 2022 | 5.36 Mn |
| Dec 31, 2021 | 4.68 Mn |
| Sep 30, 2021 | 3.75 Mn |
| Jun 30, 2021 | 4.12 Mn |
| Mar 31, 2021 | 4.02 Mn |
| Dec 31, 2020 | 3.67 Mn |
| Sep 30, 2020 | 3.51 Mn |
| Jun 30, 2020 | 3.29 Mn |
| Mar 31, 2020 | 3.61 Mn |
| Dec 31, 2019 | 3.63 Mn |
| Sep 30, 2019 | 2.64 Mn |
| Jun 30, 2019 | 1.47 Mn |
| Mar 31, 2019 | 1.67 Mn |
| Dec 31, 2018 | 1.74 Mn |
| Sep 30, 2018 | 2.10 Mn |
| Jun 30, 2018 | 1.78 Mn |
| Mar 31, 2018 | 1.42 Mn |
| Dec 31, 2017 | 1.37 Mn |
| Sep 30, 2017 | 1.38 Mn |
| Jun 30, 2017 | 1.26 Mn |
| Mar 31, 2017 | 1.31 Mn |
| Dec 31, 2016 | 1.22 Mn |
| Sep 30, 2016 | 1.35 Mn |
| Jun 30, 2016 | 1.38 Mn |
| Mar 31, 2016 | 1.17 Mn |
| Dec 31, 2015 | 1.23 Mn |
| Sep 30, 2015 | 1.12 Mn |
| Jun 30, 2015 | 975,000.00 |
| Mar 31, 2015 | 863,000.00 |
| Dec 31, 2014 | 665,000.00 |
| Sep 30, 2014 | 798,000.00 |
| Jun 30, 2014 | 879,000.00 |
| Mar 31, 2014 | 635,000.00 |
| Dec 31, 2013 | 581,000.00 |
| Sep 30, 2013 | 674,000.00 |
| Jun 30, 2013 | 640,000.00 |
| Mar 31, 2013 | 503,000.00 |